These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12877732)
1. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours. Pan CC; Chen PC; Wang LS; Lee JY; Chiang H Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732 [TBL] [Abstract][Full Text] [Related]
2. Proliferative activity and apoptosis in thymic epithelial neoplasms. Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014 [TBL] [Abstract][Full Text] [Related]
3. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Kuo TT; Chan JK Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours. Chen FF; Yan JJ; Chang KC; Lai WW; Chen RM; Jin YT Histopathology; 1996 Dec; 29(6):541-7. PubMed ID: 8971561 [TBL] [Abstract][Full Text] [Related]
5. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma. Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039 [TBL] [Abstract][Full Text] [Related]
6. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems. Walts AE; Hiroshima K; Marchevsky AM Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154 [TBL] [Abstract][Full Text] [Related]
7. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness. Chen FF; Yan JJ; Jin YT; Su IJ Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas. Stefanaki K; Rontogianni D; Kouvidou CH; Bolioti S; Delides G; Pantelidaki A; Sotsiou F; Kanavaros P Histopathology; 1997 Jun; 30(6):549-55. PubMed ID: 9205859 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM; Shahsafaei A; Miyauchi A Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677 [TBL] [Abstract][Full Text] [Related]
12. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Pan CC; Chen PC; Chou TY; Chiang H Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817 [TBL] [Abstract][Full Text] [Related]
13. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters. Salakou S; Tsamandas AC; Bonikos DS; Papapetropoulos T; Dougenis D Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213 [TBL] [Abstract][Full Text] [Related]
14. [Detection of Epstein-Barr virus, cell proliferation and apoptosis in thymic tumors]. Mai S; Xiong M; Zong Y; Li Z; Rao H Zhonghua Bing Li Xue Za Zhi; 1999 Apr; 28(2):89-92. PubMed ID: 11869513 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms. Nonaka D; Henley JD; Chiriboga L; Yee H Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270 [TBL] [Abstract][Full Text] [Related]
16. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs). Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996 [TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas. Association with p53 expression and review of the literature. Engel P; Francis D; Graem N APMIS; 1998 Apr; 106(4):449-55. PubMed ID: 9637266 [TBL] [Abstract][Full Text] [Related]
18. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression]. Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]